Point-of-Care Rapid RNA Diagnosis of Influenza Virus
Award amount
$306,564Program and phase
SBIR · Phase IAward year
2016Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CROSSLIFE TECHNOLOGIES INC.
- Proposal award date
- 2016-05-01
- Contract end date
- 2018-04-30
- UEI
- LFE6DJ6KL4E5
- Solicitation number
- PA15-269
- Topic code
- 999
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Point of Care HPV 16/18/45 DNA Test for Cervical Cancer
- Point-of-Care Rapid RNA test for Zika
- Rapid Point-of-Care RNA Diagnostic for Dengue Infection
- Point of Care HPV 16/18/45 DNA Test for Cervical Cancer
- Rapid Point-of-Care RNA Diagnostic for Dengue Infection
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Targeted Cerebral Spinal Fluid (CSF) Drug Delivery - Enclear Precision System
- An innovative, non-thiazolidinedione pan-PPAR agonist therapeutic for alcoholic hepatitis: IND-enabling safety and toxicological evaluation
- Chimeric Ligands for Induced Proximity (CLIP) platform for targeted proteome editing to treat severe alcoholic hepatitis
- A novel method of non-invasive brain stimulation to enhance motor function in chronic stroke patients
- Gene Therapy to Treat Ethanol-induced Osteoporosis Associated with Aldehyde Dehydrogenase 2 Deficiency in Post-menopausal East Asian Women
Research funding history
18 SBIR/STTR records share this UEI (2015–2023). Reported award amounts total $12,579,180. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services, National Science Foundation